Levocetirizine Dihydrochloride Tablet, Film Coated
NDC Package 85766-152-35
Package Information
Levocetirizine Dihydrochloride tablets is adults 65 years of age and older ask a doctor adults and children 12 to 64 years of age take 1 tablet (5 mg) once daily in the evening do not take more than 1 tablet (5 mg) in 24 hours ½ tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms children 6 to 11 years of age take ½ tablet (2.5 mg) once daily in the evening do not take more than ½ tablet (2.5 mg) in 24 hours children under 6 years of age do not use consumers with kidney disease do not use. This formulation utilizes a tablet, film coated delivery system. Marketed by Sportpharm Llc, this product is identified by NDC 85766-152 and is authorized under FDA application ANDA213513.
Identification & Billing
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG Oral Tablet
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85766 - Sportpharm Llc
- 85766-152 - Levocetirizine Dihydrochloride
- 85766-152-35 - 1 BOTTLE in 1 CARTON / 35 TABLET, FILM COATED in 1 BOTTLE
- 85766-152 - Levocetirizine Dihydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85766-152-35 identifies a specific commercial package of 1 bottle in 1 carton / 35 tablet, film coated in 1 bottle of Levocetirizine Dihydrochloride, a human over the counter drug labeled by Sportpharm Llc. This tablet, film coated is formulated for oral use and contains levocetirizine dihydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sportpharm Llc on October 28, 2020. The current certification is valid through December 31, 2027.
How is this Sportpharm Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85766015235. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.